ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Christina DiArcangelo has been selected as the Top International CEO of the Year 2023

New York, New York, United States - 02-14-2023 -

Christina DiArcangelo is the Chief Clinical R&D Officer of Spectral Analytics Inc., CEO of Spectral Analytics Precision Tele-Monitoring Inc., CEO and Founder of Affinity Bio Partners, CEO and Board President of Affinity Patient Advocacy, CEO and Co-Founder of AI Health Outcomes, CannaBot™ and she has been selected as the Top International CEO of the Year 2023 by the International Association of Top Professionals (IAOTP).

These special honorees are distinguished based on their outstanding professional accomplishments, academic achievements, leadership abilities, longevity in the field, other affiliations, and contributions to their communities. While inclusion with the International Association of Top Professionals is an honor, only a few members in each discipline are chosen for this distinction. All honorees are invited to attend the IAOTP's annual awards gala at the end of this year for a night to honor their achievements. www.iaotp.com/award-gala

The President of IAOTP, Stephanie Cirami, stated "We see it as a tremendous honor to have Christina as one of our own in IAOTP. Very talented and visionary, she has set new standards for success in her area. Collectively, we all felt that she would be a huge asset to our team of professionals. We hope to finally meet her at this year's Annual Awards Gala."

Christina's commitment to improving patient care is unmatched; she is a seasoned entrepreneur and CEO with over two decades of expertise in the medical cannabis, biotechnology, pharmaceutical, nutraceutical, and medical device sectors. Christina has led several innovative projects and worldwide clinical studies for the benefit of patients in her roles as CEO of Spectral Analytics Precision Tele-Monitoring, Founder and CEO of Affinity Bio Partners, Board President and CEO of Affinity Patient Advocacy, and CEO & Co-Founder of AI Health Outcomes. 

Christina has built a name for herself as the host of the podcast channel titled "I am Christina DiArcangelo," on which she has interviewed a wide variety of interesting and influential people. Affinity Patient Advocacy and Christina DiArcangelo are two of the brands that Christina has created merchandise for. 

Christina is a worldwide leader in clinical research, having contributed to the development of 25 devices, nutraceuticals, and biologics that have been approved by the FDA. While also contributing as an Opinion Columnist for CEO WorldBiz, Christina has used the resources at her disposal to advocate for patients and improve their quality of life. Christina prioritizes the health and well-being of her patients above anything else. 

Throughout her illustrious career, our fearless leader has received many awards and accolades. In 2018 she was named Top 29 Women in Medical Cannabis and 2018 Oxford Who's Who Top Tier of Excellence Lifetime. She was also awarded the honors of Top 100 Registry for Business Leaders and Professionals in 2017 and 2018. In 2017 Strathmore Who's Who Worldwide Women in Excellence Award. In 2014 she was featured in Covington Who's Who. In 2012 she received Princeton Global Network Honors, just to name a few of her awards. 

She is a devout Bahai and the proud mother of one son, Christian. She thinks that the simple acts of listening, learning, and developing have the potential to alter the course of human history by reshaping the way we treat each other and the places we call home.

Looking back, Christina believes that her professional efforts and patient advocacy will demonstrate to others that we are all the same. We all need assistance from time to time, and we should never be embarrassed or scared to ask for it. Christina's work with Affinity Bio Partners, Affinity Patient Advocacy, and Spectral Analytics Precision Tele-Monitoring is critical in giving patients hope by giving them access to the most up-to-date clinical therapies, research, trials, medication, and tools to help them improve.  Patients will finally have a voice.

For more information about Christina please visit: https://www.christinadiarcangelo.com

About IAOTP

The International Association of Top Professionals (IAOTP) is an international boutique networking organization that handpicks the world’s finest, most prestigious top professionals from different industries.  These top professionals are given an opportunity to collaborate, share their ideas, be keynote speakers, and to help influence others in their fields. This organization is not a membership that anyone can join.  You must be asked by the President or be nominated by a distinguished honorary member after a brief interview.

IAOTP’s experts have given thousands of top prestigious professionals around the world, the recognition and credibility that they deserve and have helped in building their branding empires.  IAOTP prides itself to be a one-of-a-kind boutique networking organization that hand picks only the best of the best and creates a networking platform that connects and brings these top professionals together.

For more information on IAOTP please visit: 

www.iaotp.com

Media Contacts:

Company Name: IAOTP
Full Name: Annette Natoli
Phone: 212 634 4427
Email Address: Send Email
Website: http://www.iaotp.com

For the original news story, please visit https://www.publishedpr.com/news/christina-diarcangelo-has-been-selected-as-the-top-international-ceo-of-the-year-2023/9542066.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.